Okapi Sciences
Heverlee
About Okapi Sciences
Okapi Sciences NV, a Belgium-based company with a proprietary pet therapeutics antiviral platform and five clinical/development stage candidates for treating important viral diseases. The strategic acquisition of Okapi further enhances Aratana's leadership position in pet therapeutics by bringing with it a unique combination of individuals, strong relationships with academic institutions, novel technologies and products, and favorable geographic location. Aratana plans to continue to advance the current Okapi pipeline of high value antiviral drugs, including its feline herpes and feline immunodeficiency virus franchises.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $10.8M
- Funding stage: M&A
- Last round: Grant (Jul 2013)
- Website: okapi-sciences.com
- Phone: 32 1 629 97 26
Industries & Categories
Biotechnology, Clinical Trials, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/okapi-sciences-1585804 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.